Glycyrrhizic acid, Chondroitin sulfate sulfate | Teraflex 500 mg + 400 mg capsules 100 pcs.
Special Price
$54.32
Regular Price
$63.00
In stock
SKU
BID597288
Description
Teraflex is the No. 1 drug for the treatment of osteoarthritis and osteochondrosis (2).
Teraflex is a modern chondroprotector that is manufactured in the USA in accordance with Bayer's high quality standards.
It has been proved (3) that Teraflex contributes to: - Renewal of the cartilage tissue of the joint.
- Improving joint mobility.
- Pain Relief.
And prevents the further development of the disease (4).
Teraflex has a complex effect: it helps to restore the cartilage of the joint, as well as reduce the need for the use of painkillers, increasing the safety of treatment. Unlike some other drugs of the group, it contains an enhanced daily dosage (5) of one of the most studied active substances: glucosamine and chondroitin (6).
Teraflex is available in the ideal capsule form (7), therefore: - it includes only the necessary active ingredients without unnecessary additional impurities
- is easily absorbed by the body.
Teraflex must be taken in courses, the effect of treatment can occur gradually and is designed to persist for a long time (8). The course of treatment is from 3 to 6 months: the first three weeks are prescribed by capsule 3 times a day, on subsequent days by capsule 2 times a day. Maintain joint health 2 times a year, and the joints will be grateful to you. (9)
1. Fransen M. et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015 May 74 (5): 851-8.
2. According to AI Es Health LLC obtained from the database of HFRS and dietary supplements retail audits in the Russian Federation, Teraflex is the leader in terms of sales of drugs from the 02G2C groups. Joint preparations, systemic, 02E2C. Preparations for muscle pain, systemic and 02E1O. Preparations for muscle pain for external use (OTC classification) for the periods September 2016 August 2017.
3. Chichasova N.V. Treatment of pain in patients with osteoarthrosis of various localization // Medical Council. - 2014. - No. 17. - 96-102.
4. After 3 years of therapy with Teraflex, the number of patients with radiological progression of gonarthrosis differed by 25% from the control group (p 0.05). Svetlova M.S. Pathogenetic treatment of osteoarthritis of the knee // Modern rheumatology. - 2012. - No. 3. - p. 44-49
5. Recommended daily doses when taking Teraflex capsules exceed those of some glucosamine and chondroitin preparations, according to the radar database as of July 26, 2018,
6. Kadurina T.N., Abbakumova L.N. Principles of rehabilitation of patients with connective tissue dysplasia // Attending physician. 2010. No. 4. P. 1719.
7. For combined medicines. Cole G. Evaluating Development and Production Costs: Tablets Versus Capsules. Pharmaceutical Technology Europe Vol. 5, pgs. 17 26 (1998).
8. According to a comparative study involving 100 patients with OA, the effect of pain relief persisted for 3 months after discontinuation of treatment. Alekseeva L.I., Kashevarova N.G., Sharapova E.P., Zaitseva E.M., Severinova M.V. Comparison of the constant and intermittent treatment of patients with osteoarthritis of the knee joints with the combined drug Teraflex // Scientific and Practical Rheumatology. - 200 - No. 3. - p. 68-72.
9. Federal clinical guidelines for the diagnosis and treatment of osteoarthritis, Association of rheumatologists of Russia, 2016, 19 pp .
Teraflex is the No. 1 drug for the treatment of osteoarthritis and osteochondrosis (2).
Teraflex is a modern chondroprotector that is manufactured in the USA in accordance with Bayer's high quality standards.
It has been proved (3) that Teraflex contributes to: - Renewal of the cartilage tissue of the joint.
- Improving joint mobility.
- Pain Relief.
And prevents the further development of the disease (4).
Teraflex has a complex effect: it helps to restore the cartilage of the joint, as well as reduce the need for the use of painkillers, increasing the safety of treatment. Unlike some other drugs of the group, it contains an enhanced daily dosage (5) of one of the most studied active substances: glucosamine and chondroitin (6).
Teraflex is available in the ideal capsule form (7), therefore: - it includes only the necessary active ingredients without unnecessary additional impurities
- is easily absorbed by the body.
Teraflex must be taken in courses, the effect of treatment can occur gradually and is designed to persist for a long time (8). The course of treatment is from 3 to 6 months: the first three weeks are prescribed by capsule 3 times a day, on subsequent days by capsule 2 times a day. Maintain joint health 2 times a year, and the joints will be grateful to you. (9)
1. Fransen M. et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015 May 74 (5): 851-8.
2. According to AI Es Health LLC obtained from the database of HFRS and dietary supplements retail audits in the Russian Federation, Teraflex is the leader in terms of sales of drugs from the 02G2C groups. Joint preparations, systemic, 02E2C. Preparations for muscle pain, systemic and 02E1O. Preparations for muscle pain for external use (OTC classification) for the periods September 2016 August 2017.
3. Chichasova N.V. Treatment of pain in patients with osteoarthrosis of various localization // Medical Council. - 2014. - No. 17. - 96-102.
4. After 3 years of therapy with Teraflex, the number of patients with radiological progression of gonarthrosis differed by 25% from the control group (p 0.05). Svetlova M.S. Pathogenetic treatment of osteoarthritis of the knee // Modern rheumatology. - 2012. - No. 3. - p. 44-49
5. Recommended daily doses when taking Teraflex capsules exceed those of some glucosamine and chondroitin preparations, according to the radar database as of July 26, 2018,
6. Kadurina T.N., Abbakumova L.N. Principles of rehabilitation of patients with connective tissue dysplasia // Attending physician. 2010. No. 4. P. 1719.
7. For combined medicines. Cole G. Evaluating Development and Production Costs: Tablets Versus Capsules. Pharmaceutical Technology Europe Vol. 5, pgs. 17 26 (1998).
8. According to a comparative study involving 100 patients with OA, the effect of pain relief persisted for 3 months after discontinuation of treatment. Alekseeva L.I., Kashevarova N.G., Sharapova E.P., Zaitseva E.M., Severinova M.V. Comparison of the constant and intermittent treatment of patients with osteoarthritis of the knee joints with the combined drug Teraflex // Scientific and Practical Rheumatology. - 200 - No. 3. - p. 68-72.
9. Federal clinical guidelines for the diagnosis and treatment of osteoarthritis, Association of rheumatologists of Russia, 2016, 19 pp .
Description
Teraflex is the No. 1 drug for the treatment of osteoarthritis and osteochondrosis (2).
Teraflex is a modern chondroprotector that is manufactured in the USA in accordance with Bayer's high quality standards.
It has been proved (3) that Teraflex contributes to: - Renewal of the cartilage tissue of the joint.
- Improving joint mobility.
- Pain Relief.
And prevents the further development of the disease (4).
Teraflex has a complex effect: it helps to restore the cartilage of the joint, as well as reduce the need for the use of painkillers, increasing the safety of treatment. Unlike some other drugs of the group, it contains an enhanced daily dosage (5) of one of the most studied active substances: glucosamine and chondroitin (6).
Teraflex is available in the ideal capsule form (7), therefore: - it includes only the necessary active ingredients without unnecessary additional impurities
- is easily absorbed by the body.
Teraflex must be taken in courses, the effect of treatment can occur gradually and is designed to persist for a long time (8). The course of treatment is from 3 to 6 months: the first three weeks are prescribed by capsule 3 times a day, on subsequent days by capsule 2 times a day. Maintain joint health 2 times a year, and the joints will be grateful to you. (9)
1. Fransen M. et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015 May 74 (5): 851-8.
2. According to AI Es Health LLC obtained from the database of HFRS and dietary supplements retail audits in the Russian Federation, Teraflex is the leader in terms of sales of drugs from the 02G2C groups. Joint preparations, systemic, 02E2C. Preparations for muscle pain, systemic and 02E1O. Preparations for muscle pain for external use (OTC classification) for the periods September 2016 August 2017.
3. Chichasova N.V. Treatment of pain in patients with osteoarthrosis of various localization // Medical Council. - 2014. - No. 17. - 96-102.
4. After 3 years of therapy with Teraflex, the number of patients with radiological progression of gonarthrosis differed by 25% from the control group (p 0.05). Svetlova M.S. Pathogenetic treatment of osteoarthritis of the knee // Modern rheumatology. - 2012. - No. 3. - p. 44-49
5. Recommended daily doses when taking Teraflex capsules exceed those of some glucosamine and chondroitin preparations, according to the radar database as of July 26, 2018,
6. Kadurina T.N., Abbakumova L.N. Principles of rehabilitation of patients with connective tissue dysplasia // Attending physician. 2010. No. 4. P. 1719.
7. For combined medicines. Cole G. Evaluating Development and Production Costs: Tablets Versus Capsules. Pharmaceutical Technology Europe Vol. 5, pgs. 17 26 (1998).
8. According to a comparative study involving 100 patients with OA, the effect of pain relief persisted for 3 months after discontinuation of treatment. Alekseeva L.I., Kashevarova N.G., Sharapova E.P., Zaitseva E.M., Severinova M.V. Comparison of the constant and intermittent treatment of patients with osteoarthritis of the knee joints with the combined drug Teraflex // Scientific and Practical Rheumatology. - 200 - No. 3. - p. 68-72.
9. Federal clinical guidelines for the diagnosis and treatment of osteoarthritis, Association of rheumatologists of Russia, 2016, 19 pp .
latin name
Theraflex
Release form
Capsules.
Packing
100 pcs
Pharmacological action
Teraflex is a modern chondroprotector that contains components related to the cartilage tissue of the joints - Glucosamine and Chondroitin. Thanks to this composition, Teraflex helps to renew cartilage, helps to reduce pain and improve joint mobility, and also prevents the further development of the disease.
Stimulates the regeneration of cartilage. Glucosamine and chondroitin sodium sulfate are involved in the synthesis of connective tissue, helping to prevent the destruction of cartilage and stimulating tissue regeneration.
In the treatment of osteoarthrosis relieves the symptoms of the disease and reduces the need for NSAIDs.
It is recommended to start treatment with Teraflex Advance, which quickly reduces pain and at the same time begins to stimulate the renewal of cartilage.
Then it is advisable to take Teraflex to prolong the analgesic effect and protect cartilage.
Indications
Degenerative degenerative diseases of the joints and spine: osteoarthritis of the I – III stage of osteochondrosis.
Contraindications
Hypersensitivity
severe chronic renal failure
pregnancy
lactation
children under 15 years of age.
Precautions: diabetes, bleeding tendency, bronchial asthma.
Use during pregnancy and lactation
Contraindicated in pregnancy and lactation.
Special instructions
If adverse effects from the gastrointestinal tract appear, the drug dose should be reduced by 2 times, and if there is no improvement, stop the drug.
Composition
1 capsule contains:
Active substances:
glucosamine hydrochloride - 500 mg,
chondroitin sodium sulfate - 400 mg.
Excipients:
sodium sulfate,
stearic acid,
magnesium stearate,
manganese sulfate.
Dosage and administration
Inside, regardless of the meal, with a little water.
Adults and children over 15 years of age - 1 capsule is prescribed in the first 3 weeks. 3 times a day on subsequent days - 1 caps. 2 times a day.
The recommended duration of treatment is 3 to 6 months.
If necessary, repeated courses of treatment are possible, the duration of which is set individually.
Side effects
Teraflex is well tolerated by patients.
Gastrointestinal disorders (epigastric pain, flatulence, diarrhea, constipation), dizziness, headache, leg pain and peripheral edema, drowsiness, insomnia, tachycardia, allergic reactions are possible.
Storage conditions
Store in a dry, dark place at temperatures below 25 РC.
Keep out of the reach and sight of children.
Shelf life
3 years.
Conditions for the drugstore from
Without a prescription
dosage form
capsules
Teraflex is the No. 1 drug for the treatment of osteoarthritis and osteochondrosis (2).
Teraflex is a modern chondroprotector that is manufactured in the USA in accordance with Bayer's high quality standards.
It has been proved (3) that Teraflex contributes to: - Renewal of the cartilage tissue of the joint.
- Improving joint mobility.
- Pain Relief.
And prevents the further development of the disease (4).
Teraflex has a complex effect: it helps to restore the cartilage of the joint, as well as reduce the need for the use of painkillers, increasing the safety of treatment. Unlike some other drugs of the group, it contains an enhanced daily dosage (5) of one of the most studied active substances: glucosamine and chondroitin (6).
Teraflex is available in the ideal capsule form (7), therefore: - it includes only the necessary active ingredients without unnecessary additional impurities
- is easily absorbed by the body.
Teraflex must be taken in courses, the effect of treatment can occur gradually and is designed to persist for a long time (8). The course of treatment is from 3 to 6 months: the first three weeks are prescribed by capsule 3 times a day, on subsequent days by capsule 2 times a day. Maintain joint health 2 times a year, and the joints will be grateful to you. (9)
1. Fransen M. et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015 May 74 (5): 851-8.
2. According to AI Es Health LLC obtained from the database of HFRS and dietary supplements retail audits in the Russian Federation, Teraflex is the leader in terms of sales of drugs from the 02G2C groups. Joint preparations, systemic, 02E2C. Preparations for muscle pain, systemic and 02E1O. Preparations for muscle pain for external use (OTC classification) for the periods September 2016 August 2017.
3. Chichasova N.V. Treatment of pain in patients with osteoarthrosis of various localization // Medical Council. - 2014. - No. 17. - 96-102.
4. After 3 years of therapy with Teraflex, the number of patients with radiological progression of gonarthrosis differed by 25% from the control group (p 0.05). Svetlova M.S. Pathogenetic treatment of osteoarthritis of the knee // Modern rheumatology. - 2012. - No. 3. - p. 44-49
5. Recommended daily doses when taking Teraflex capsules exceed those of some glucosamine and chondroitin preparations, according to the radar database as of July 26, 2018,
6. Kadurina T.N., Abbakumova L.N. Principles of rehabilitation of patients with connective tissue dysplasia // Attending physician. 2010. No. 4. P. 1719.
7. For combined medicines. Cole G. Evaluating Development and Production Costs: Tablets Versus Capsules. Pharmaceutical Technology Europe Vol. 5, pgs. 17 26 (1998).
8. According to a comparative study involving 100 patients with OA, the effect of pain relief persisted for 3 months after discontinuation of treatment. Alekseeva L.I., Kashevarova N.G., Sharapova E.P., Zaitseva E.M., Severinova M.V. Comparison of the constant and intermittent treatment of patients with osteoarthritis of the knee joints with the combined drug Teraflex // Scientific and Practical Rheumatology. - 200 - No. 3. - p. 68-72.
9. Federal clinical guidelines for the diagnosis and treatment of osteoarthritis, Association of rheumatologists of Russia, 2016, 19 pp .
latin name
Theraflex
Release form
Capsules.
Packing
100 pcs
Pharmacological action
Teraflex is a modern chondroprotector that contains components related to the cartilage tissue of the joints - Glucosamine and Chondroitin. Thanks to this composition, Teraflex helps to renew cartilage, helps to reduce pain and improve joint mobility, and also prevents the further development of the disease.
Stimulates the regeneration of cartilage. Glucosamine and chondroitin sodium sulfate are involved in the synthesis of connective tissue, helping to prevent the destruction of cartilage and stimulating tissue regeneration.
In the treatment of osteoarthrosis relieves the symptoms of the disease and reduces the need for NSAIDs.
It is recommended to start treatment with Teraflex Advance, which quickly reduces pain and at the same time begins to stimulate the renewal of cartilage.
Then it is advisable to take Teraflex to prolong the analgesic effect and protect cartilage.
Indications
Degenerative degenerative diseases of the joints and spine: osteoarthritis of the I – III stage of osteochondrosis.
Contraindications
Hypersensitivity
severe chronic renal failure
pregnancy
lactation
children under 15 years of age.
Precautions: diabetes, bleeding tendency, bronchial asthma.
Use during pregnancy and lactation
Contraindicated in pregnancy and lactation.
Special instructions
If adverse effects from the gastrointestinal tract appear, the drug dose should be reduced by 2 times, and if there is no improvement, stop the drug.
Composition
1 capsule contains:
Active substances:
glucosamine hydrochloride - 500 mg,
chondroitin sodium sulfate - 400 mg.
Excipients:
sodium sulfate,
stearic acid,
magnesium stearate,
manganese sulfate.
Dosage and administration
Inside, regardless of the meal, with a little water.
Adults and children over 15 years of age - 1 capsule is prescribed in the first 3 weeks. 3 times a day on subsequent days - 1 caps. 2 times a day.
The recommended duration of treatment is 3 to 6 months.
If necessary, repeated courses of treatment are possible, the duration of which is set individually.
Side effects
Teraflex is well tolerated by patients.
Gastrointestinal disorders (epigastric pain, flatulence, diarrhea, constipation), dizziness, headache, leg pain and peripheral edema, drowsiness, insomnia, tachycardia, allergic reactions are possible.
Storage conditions
Store in a dry, dark place at temperatures below 25 РC.
Keep out of the reach and sight of children.
Shelf life
3 years.
Conditions for the drugstore from
Without a prescription
dosage form
capsules
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review